Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 2/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 6/20 | 0.36 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.36 |
| ▸ | CACNA1G | O43497 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25528339 | 0.88 | PARP1 (0.41) | BRD4ROCK2ROCK1CACNA1GTHRB | |
| SCHEMBL25528328 | 0.78 | BRD4 (0.43) | BRD4ROCK2ROCK1DPP4 | |
| SCHEMBL25528351 | 0.77 | BRD4 (0.34) | BRD4CACNA1GALDH1A1GAATHRB | |
| SCHEMBL25529692 | 0.77 | ROCK2 (0.52) | ROCK2ROCK1 | |
| SCHEMBL25528758 | 0.76 | PARP1 (0.42) | BRD4ROCK2CACNA1GTHRB | |
| SCHEMBL25528752 | 0.74 | PARP1 (0.42) | BRD4ROCK2ROCK1CACNA1GTHRB | |
| SCHEMBL25529498 | 0.70 | MAPT (0.48) | ROCK2ROCK1GAATHRB | |
| SCHEMBL25529068 | 0.70 | ROCK2 (0.43) | ROCK2ROCK1 | |
| SCHEMBL25529501 | 0.69 | ROCK1 (0.47) | BRD4ROCK2ROCK1 | |
| SCHEMBL25529500 | 0.69 | ROCK2 (0.59) | BRD4ROCK2ROCK1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023093787-A1 | BENZODIAZEPINE COMPOUND AND APPLICATION THEREOF AS RHO KINASE INHIBITOR | 成都奥睿药业有限公司 | 2023-06-01 | — | — | WO | disclosed |